GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Institutional Ownership

LBT Innovations (ASX:LBT) Institutional Ownership : 0.49% (As of Jun. 09, 2024)


View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LBT Innovations's institutional ownership is 0.49%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LBT Innovations's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LBT Innovations's Float Percentage Of Total Shares Outstanding is 0.00%.


LBT Innovations Institutional Ownership Historical Data

The historical data trend for LBT Innovations's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBT Innovations Institutional Ownership Chart

LBT Innovations Historical Data

The historical data trend for LBT Innovations can be seen below:

2019-06-30 2019-07-31 2019-08-31 2019-09-30 2019-10-31 2019-11-30
Institutional Ownership 1.90 1.90 1.90 1.90 1.90 0.49

LBT Innovations Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


LBT Innovations (ASX:LBT) Business Description

Traded in Other Exchanges
N/A
Address
16 Anster Street, Adelaide, SA, AUS, 5000
LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines